Jan 21, 2022 04:09 AM (GMT+8) · EqualOcean
In 2021, although the volatility of A-share market increased, securities private placement still achieved good results. On the one hand, the scale of assets under management in the private placement market officially reached the 6 trillion yuan mark, and the 10 billion yuan camp expanded again; On the other hand, the ability of private placement to make money is still obvious. Among the 10 billion yuan private placement, the annual highest yield is nearly 80%. According to the data of private placement network, since the beginning of this year, there have been as many as 19 pharmaceutical stocks investigated by 10 billion yuan private placement, including East China medicine, Oriental biology, Jiu'An medical, etc. These private equity giants prefer small and medium-sized market value targets. Data show that among the listed companies surveyed by the 10 billion yuan private placement since this year, only seven companies with a market value of more than 50 billion yuan, and nearly 90% of the companies with a market value of less than 50 billion yuan.